Structure |
Chemical Name |
CAS |
MF |
|
N-[1-[(3R)-1-(1-oxo-2-propen-1-yl)-3-piperidinyl]-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]- 2-Propenamide |
2031255-27-1 |
C28H26N6O3 |
|
4-amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one |
|
C8H11FN3O4S- |
|
Anastrozole Impurity 3 |
|
|
|
Cephalexin Impurity 4 |
|
C16H17N3O4S |
|
Rivaroxaban Impurity 42 |
|
|
|
(R,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3-hydroxy-5-oxohept-6-enoic acid |
1422514-05-3 |
C22H26FN3O6S |
|
Atorvastatin 2-Fluoro t-Butyl Ester |
1099474-28-8 |
C40H47FN2O5 |
|
Cabozantinib Impurity C |
|
|
|
(3R,4R)-N,4-dimethyl-piperidin-3-amine |
1354469-76-3 |
C7H16N2 |
|
4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine |
952518-97-7 |
C9H7N5 |
|
5-phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde |
881676-90-0 |
C16H12N2O3S |
|
3-Piperidinemethanol, 4-(4-fluorophenyl)-1-methyl-, (3R,4R)- |
100332-12-5 |
C13H18FNO |
|
r-Cytidine |
13913-16-1 |
C9H13N3O5 |
|
Pyridine, 4-chloro-2-(chloromethyl)-3-methyl- |
168167-48-4 |
C7H7Cl2N |
|
1,2,4-Triazolo(3,4-b)benzothiazole-5-methanol |
69243-49-8 |
C9H7N3OS |
|
Benzoicacid, 2-sulfino- |
13165-80-5 |
C7H6O4S |
|
Benzenemethanamine, a-ethyl-N,N-dimethyl- |
3330-05-0 |
C11H17N |
|
CIS-1,2-BIS(AMINOMETHYL)CYCLOBUTANE |
15286-88-1 |
C6H14N2 |
|
Verapamil Related Compound A (50 mg) (3,4-Dimethoxy-alpha-[3-(methylamino)propyl]-alpha-(1-methylethyl)-benzeneacetonitrile monohydrochloride) |
67775-97-7 |
C17H27ClN2O2 |
|
Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4R)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]- |
1255529-23-7 |
C24H30ClN7O4S |
|
Palonosetron |
135729-56-5 |
C19H22N2O |
|
EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4S)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]- |
1255529-25-9 |
C24H30ClN7O4S |
|
N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-2-chloro-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
923036-25-3 |
C20H24ClN5 |
|
8-Chloro-11-(piperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine |
117811-20-8 |
C19H17ClN2 |
|
Fludarabine Phosphate iMpurity B |
149297-79-0 |
C5H5N5O |
|
nifedipine iMpurity C |
111304-31-5 |
C12H11NO5 |
|
RofluMilast related substance |
475271-62-6 |
C16H14Cl2N2O3 |
|
Ritonavir EP Impurity I |
165315-26-4 |
C36H46N6O5S2 |
|
(6R-trans)-7-[(2,2-diMethyl-1-oxopropyl)aMino]-3-Methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2- |
146794-70-9 |
C13H18N2O4S |
|
3-[3-[[[(7S)-3,4-DiMethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]Methyl]MethylaMino]propyl]-1,3-dihydro-7,8-diMethoxy-H-3-benzazepin-2-one |
1086026-31-4 |
C27H34N2O5 |
|
7-[(3R)-3-[(N-Acetyl)AMino]-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoroMethyl)-1,2,4-triazolo[4,3-a]pyrazine |
1379666-94-0 |
C18H17F6N5O2 |
|
2-[[Methyl[(3S)-3-(1-naphthalenyloxy)-3-(2-thienyl)propyl]aMino]carbonyl]benzoic Acid |
199191-67-8 |
C26H23NO4S |
|
Labetalol IMpurity B |
802620-01-5 |
C20H25NO4 |
|
Ritonavir EP Impurity C |
1010808-43-1 |
C25H29N3O4S |
|
AcetaMide, N,N-bis[2-(7-Methoxy-1-naphthalenyl)ethyl]- |
1385018-58-5 |
C28H29NO3 |
|
(S)-quinuclidin-3-aMine |
120570-05-0 |
C7H14N2 |
|
Benzene, 1-chloro-2-nitroso- |
932-33-2 |
C6H4ClNO |
|
IMp. A (EP): Ethyl 4-[(11RS)-8-Chloro-11-hydroxy-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]piperidine-1-carboxylate |
38092-95-4 |
C19H20N2 |
|
PeMetrexed EP IMpurity E |
182009-04-7 |
C20H21N5O6 |
|
Itraconazole iMpurity A |
|
|
|
(S)-BoroLeu-(-)-Pinanediol-CF3COOH |
477254-69-6 |
C17H29BF3NO4 |
|
Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, MonoMethyl ester |
3333-46-8 |
C5H8O6 |
|
Valsartan D9 |
1089736-73-1 |
C24H29N5O3 |
|
N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
1252883-90-1 |
C20H25N5 |
|
P219490 |
937370-10-0 |
C20H21N5Na2O6** |
|
(S)-4-(TERT-BUTOXY)-2-ISOPROPYL-4-OXOBUTANOIC ACID |
134807-43-5 |
C11H20O4 |
|
Acarbose D-Fructose IMpurity |
1013621-79-8 |
C25H43NO18 |
|
2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-aMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-, 1-ethyl 9-(1-Methylethyl) ester, 5-oxide |
1422284-16-9 |
C18H28N5O10P |
|
(R)-α-[2-(1-naphthalenyloxy)ethyl]-benzeneMethanol |
156453-53-1 |
C19H18O2 |
|
N-FORMYL-1-(2-AMINO-1-(4-METHOXYPHENYL)ETHYL)CYCLOHEXANOL |
272788-07-5 |
C16H23NO3 |
|
Acotiamide Impurity |
198470-83-6 |
C20H21N2NaO4S |
|
Terbutaline Impurity |
52144-90-8 |
C26H29NO3 |
|
methyl (41S,12R,13aR)-13a-ethyl-12-
hydroxy-2,3,41,5,6,12,13,13aoctahydro-
1H-indolo[3,2,1-
de]pyrido[3,2,1-ij][1,5]naphthyridine-
12-carboxylate |
83508-83-2 |
C21H26N2O3 |
|
ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate |
473465-11-1 |
C18H18N2O3S |
|
(1S,2S,3R,5S)-3-(7-((1S,2R)-2-(3,4-difluorophenyl)cyclopropylaMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
2096989-56-7 |
C23H28F2N6O4S |
|
Fosaprepitant iMpurity |
|
|
|
Apixaban iMpurity 1 |
|
|
|
Azilsartan iMpurity H |
|
|
|
Azilsartan iMpurity M |
|
|
|
bortezoMib iMpurity F |
|
|
|
cefoxitin iMpurity A |
|
|
|
3-Morpholinone, 4-(2-aMinophenyl)- |
1082588-73-5 |
C10H12N2O2 |
|
(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(4-(trifluoroMethyl)phenyl)propan-1-aMine |
1428185-71-0 |
C22H22F3N |
|
1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo- |
344418-92-4 |
C16H20N6O |
|
Erlotinib impurity A |
183321-85-9 |
C21H20ClN3O3 |
|
1,3-Dioxane-4,6-dione, 5-[[(3,4-diMethoxyphenyl)aMino]Methylene]-2,2-diMethyl- |
213699-53-7 |
C15H17NO6 |
|
(2R,3R)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride |
1333998-21-2 |
C20H19ClF7NO2 |
|
Budesonide iMpurity |
192057-49-1 |
C24H32O6 |
|
dextroMethorphan iMpurity |
|
|
|
Fluticasone IMpurity |
397864-58-3 |
C27H30F2O6S |
|
Valdecoxib iMpurity |
|
|
|
Fluconazole IMpurity-H |
|
|
|
Retigabine Dihydrochloride Impurity |
1432063-93-8 |
C16H19ClFN3O2 |
|
Adrenaline IMpurity F |
78995-75-2 |
C9H13NO5S |
|
Anastrozole IMpurity (alfa1 , alfa1, alfa3, alfa3-TetraMethyl-5-(1H-1,2,4-triazol-1-ylMethyl)-1,3-Benzenediacetic acid) |
1338800-81-9 |
C17H21N3O4 |
|
AtracuriuM IMpurity C1 (trans-Monoacrylate) |
|
|
|
AzithroMycin IMpurity C |
|
|
|
AztreonaM IMpurity D |
|
|
|
Busulfan IMpurity 1 |
1797106-48-9 |
C6H14O5S2 |
|
Deferasirox Ethyl Ester |
201530-79-2 |
C23H19N3O4 |
|
MetoclopraMide IMpurity F |
38339-95-6 |
C13H20ClN3O2 |
|
Metronidazole IMpurity E |
|
|
|
Propofol IMpurity H |
|
|
|
R-(-)-O-DesMethyl-Venlafaxine-d6 |
1062609-96-4 |
C16H25NO2 |
|
Ribavirin IMp. C (EP) |
|
|
|
SalMeterol IMpurity B |
|
C25H37NO4 |
|
Sitagliptin N-Phoshate IMpurity |
1351498-25-3 |
C16H16F6N5O4P |
|
SulbactaM IMpurity E |
|
|
|
TriMethopriM IMpurity A |
213745-86-9 |
C15H20N4O3 |
|
Varenicline Metadinitro IMpurity |
|
|
|
1-(4-methoxyphenyl)-2-methylpropan-2-amine |
56490-94-9 |
C11H17NO |
|
product/153101 |
|
|
|
2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine |
877858-27-0 |
C12H12N2O |
|
Apixaban IMpurity(BMS-778960-01) |
|
|
|
1,3,5-Tri-O-benzoyl-2-deoxy-2-fluoro-α-D-ribofuranose |
704916-12-1 |
C26H21FO7 |
|
Chlorpheniramine |
78539-96-5 |
C16H19ClN2 |
|
9-(2,5-d|Dioxo-L-3-aMino-1-pyrrolidineacetic acid)-10-deglycine DaptoMycin |
121869-35-0 |
C72H99N17O25 |
|
(1S,2S,5S)-4-[2-[2-(6,6-DiMethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]Morpholine |
38284-47-8 |
C17H31NO2 |
|
[4-(4-AMino-6-hydroxy-7-Methoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)Methanone |
105356-89-6 |
C18H23N5O4 |
|
2,2'-[4-(2-Methylpropoxy)-1,3-phenylene]bis[4-Methyl-5-thiazolecarboxylic Acid 5,5'-DiMethyl Ester |
1330632-47-7 |
C22H24N2O5S2 |